Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-02-09 @ 3:39 PM
Study NCT ID:
NCT01103960
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2010-04-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-04-13
First Submit QC Date:
None
Study First Post Date:
2010-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-21
Results First Submit QC Date:
None
Results First Post Date:
2012-09-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-17
Last Update Post Date:
2014-06-27
Last Update Post Date Type:
ESTIMATED